Online Laser Training

APRIL 4, 2024

Our Online Laser Training International Programme Director, Dr Godfrey Town has been re-certified from 1st May 2023 by RPA 2000 for a further five years to act as a Laser Protection Adviser (LPA) and Dr Town holds this for medical, research and teaching.

Portfolios 78

Portfolios Training Office Medical 78

Online Laser Training

APRIL 4, 2024

Our Online Laser Training International Programme Director, Dr Godfrey Town has been re-certified from 1st May 2023 by RPA 2000 for a further five years to act as a Laser Protection Adviser (LPA) and Dr Town holds this for medical, research and teaching.

Portfolios 78

Portfolios Training Office Medical 78

Aesthetic Advancements Institute (AAI)

SEPTEMBER 28, 2023

The medical aesthetic industry is undergoing a remarkable evolution, with non-invasive treatments at the forefront. For practitioners keen on expanding their portfolio and offering cutting-edge procedures, understanding the year’s top tweakments is essential.

Chemical Peels 36

Chemical Peels Treatments Microneedling Portfolios 36

Online Laser Training

MARCH 28, 2023

The RPA 2000 LPA certificate is evidence of competence in radiation protection for non-ionising radiation and Dr Town holds this for medical, research and teaching. These jurisdictions in England include London, Essex and Nottinghamshire.

Portfolios 60

Portfolios Training Office Medical 60

The Dermatology Digest

MARCH 27, 2024

Stern will join the global leadership team and will be responsible for leading the portfolio and brand strategies. Lexi will be a powerful partner in working with our customers globally to fulfill our shared purpose of fueling people’s confidence through medical aesthetics.” Most recently, Ms.

Office 36

Office Portfolios Branding Marketing 36

Aesthetics Advisor

SEPTEMBER 15, 2023

However, medications that are already authorized are just a small percentage of what's been studied. Many researchers are still trying to find and develop other medications that can treat or prevent COVID-19. The product is authorized as a medical device targeting COVID-19 in India, Israel, Bahrain, Indonesia and Thailand.

Hospital 69

Hospital Clinic Marketing Medical 69

The Dermatology Digest

DECEMBER 21, 2023

The two distribution agreements for the Evolysse /Estyme fillers portfolio will grant Evolus the ability to offer filler solutions to cover mid-face, nasolabial folds, and lip indications in Europe plus an eye product line in the U.S. We are extremely excited to expand our partnership with Evolus beyond the U.S. to now include the U.K.

Marketing 36

Marketing Sales Branding Portfolios 36